Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Assumptions & Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing prevalence of chronic conditions such as diabetes is estimated to increase the demand
for needle-free injectors
4.2.2 Capacity of needle-free injectors to support homecare
4.2.3 Growing biopharmaceuticals industry
4.2.4 Increasing investments in the market
4.2.5 Drivers Impact Analysis
4.3 Restraints
4.3.1 Risks of Cross Contamination
4.3.2 High Cost
4.3.3 Restraints Impact Analysis
4.4 Opportunity
4.4.1 Increasing campaigns of vaccination in developing economies of the Asia Pacific region
4.5 Macroeconomic Indicators
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D & Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review
?
5.2 Porter's Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
6 Global Needle Free Injection Market, By Product
6.1 Introduction
6.2 Fillable Needle-Free Injectors
6.3 Prefilled Needle-Free Injectors
7 Global Needle Free Injection Market, By Technology
7.1 Introduction
7.2 Jet-Based
7.3 Spring-Based
7.4 Laser-Powered
8 Global Needle Free Injection Market, By Usability
8.1 Introduction
8.2 Reusable Needle-Free Injectors
8.3 Disposable Needle-Free Injectors
9 Global Needle Free Injection Market, By Type of Medication
9.1 Introduction
9.2 Liquid-Based Needle Free Injectors
9.3 Powder-Based Needle Free Injectors
9.4 Projectile/Depot-Based Needle Free Injectors
10 Global Needle Free Injection Market, By Site of Delivery
10.1 Introduction
10.2 Intra dermal injectors
10.3 Intramuscular injectors
10.4 Subcutaneous injectors
11 Global Needle Free Injection Market, By Application
11.1 Introduction
11.2 Vaccination
11.3 Insulin Delivery
11.4 Oncology
12 Global Needle Free Injection Market, By End Users
12.1 Introduction
12.2 Hospitals and Clinics
12.3 Ambulatory Surgical Centres
12.4 Homecare Settings
13 Global Needle Free Injection Market, By Region
13.1 Introduction
13.2 Americas
13.2.1 North America
13.2.1.1 U.S
13.2.1.2 Canada
13.2.2 South America
13.3 Europe
13.3.1 Western Europe
13.3.1.1 Germany
13.3.1.2 France
13.3.1.3 U.K
13.3.1.4 Italy
13.3.1.5 Spain
13.3.1.6 Rest of Western Europe
13.3.2 Eastern Europe
13.4 Asia Pacific
13.4.1 China
13.4.2 India
13.4.3 Japan
13.4.4 South Korea
13.4.5 Rest of Asia Pacific
13.5 Middle East & Africa
13.6 The Middle East
13.6.1 Africa
14 Competitive Landscape
14.1 Introduction
14.2 Recent Developments, 2014-2018
15 Company Profiles
15.1 Antares Pharma Inc.
15.1.1 Company Overview
15.1.2 Financial Overview
15.1.3 Products Offering
15.1.4 Key Developments
15.1.5 SWOT Analysis
15.1.6 Key Strategy
15.2 Endo Pharmaceuticals Inc.
15.2.1 Company Overview
15.2.2 Financial Overview
15.2.3 Products Offering
15.2.4 Key Developments
15.2.5 SWOT Analysis
15.2.6 Key Strategy
15.3 PharmaJet, Inc
15.3.1 Company Overview
15.3.2 Financial Overview
15.3.3 Products Offering
15.3.4 Key Developments
15.3.5 SWOT Analysis
15.3.6 Key Strategy
15.4 Inovio Pharmaceuticals Inc.
15.4.1 Company Overview
15.4.2 Financial Overview
15.4.3 Products Offering
15.4.4 Key Developments
15.4.5 SWOT Analysis
15.4.6 Key Strategy
15.5 Medical International Technology, Inc.
15.5.1 Company Overview
15.5.2 Financial Overview
15.5.3 Products Offering
15.5.4 Key Developments
15.5.5 SWOT Analysis
15.5.6 Key Strategy
15.6 INJEX Pharma GmBH
15.6.1 Company Overview
15.6.2 Financial Overview
15.6.3 Products Offering
15.6.4 Key Developments
15.6.5 SWOT Analysis
15.6.6 Key Strategy
15.7 National Medical Products Inc.
15.7.1 Company Overview
15.7.2 Financial Overview
15.7.3 Products Offering
15.7.4 Key Developments
15.7.5 SWOT Analysis
15.7.6 Key Strategy
15.8 European Pharma Group
15.8.1 Company Overview
15.8.2 Financial Overview
15.8.3 Products Offering
15.8.4 Key Developments
15.8.5 SWOT Analysis
15.8.6 Key Strategy
15.9 PenJet Corporation
15.9.1 Company Overview
15.9.2 Financial Overview
15.9.3 Products Offering
15.9.4 SWOT Analysis
15.9.5 Key Strategy
15.1 Valeritas Holdings, Inc.
15.10.1 Company Overview
15.10.2 Financial Overview
15.10.3 Products Offering
15.10.4 Key Developments
15.10.5 SWOT Analysis
15.10.6 Key Strategy
15.11 CROSSJECT
15.11.1 Company Overview
15.11.2 Financial Overview
15.11.3 Products Offering
15.11.4 Key Developments
15.11.5 SWOT Analysis
15.11.6 Key Strategy
15.12 MIKA MEDICAL CO.
15.12.1 Company Overview
15.12.2 Financial Overview
15.12.3 Products Offering
15.12.4 Key Developments
15.12.5 SWOT Analysis
15.12.6 Key Strategy
15.13 D'Antonio Consultants International, Inc.
15.13.1 Company Overview
15.13.2 Financial Overview
15.13.3 Products Offering
15.13.4 Key Developments
15.13.5 SWOT Analysis
15.13.6 Key Strategy
16 Appendix
16.1 Discussion Blue Print